Drug Eluting Stents

Oct 1st, 2008
Benefits in attending: Understand the background and development of the EMEA/CHMP guideline. Gain an understanding of the CEFT guideline. Discuss the impact of the emerging guidelines on your company strategy. Clarify the competent authorities' expectations on new and emerging technologies. Plan your regulatory strategy with your notified body to achieve timely CE Marking. Discover how to survive the pitfalls and challenges of the guidelines. Consider the clinical evaluation of your product.
Page 1 of 25
Next Page